Clinical trial

CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn®…

NCT00366925 · Otsuka Frankfurt Research Institute GmbH, Industry · Completed

Key facts

NCT number NCT00366925
Title CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis
Official title Randomized Controlled Multicenter Investigation to Compare the Efficacy and Safety of Adacolumn® Granulocytes, Monocytes/Macrophage Apheresis Device, 5 Versus 10 Treatments, in Patients With Active Ulcerative Colitis
Lead sponsor Otsuka Frankfurt Research Institute GmbH, Industry
Status Completed
Study type Interventional
Conditions Ulcerative Colitis
Intervention type Device
Interventions Adacolumn®
Enrollment 174
Start date Apr 1, 2006
Primary completion Feb 1, 2008
Completion Jul 1, 2008
First posted Aug 22, 2006
Last update posted Apr 28, 2009
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies